These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26700670)

  • 1. MicroRNA-148a represents an independent prognostic marker in bladder cancer.
    Ma L; Xu Z; Xu C; Jiang X
    Tumour Biol; 2016 Jun; 37(6):7915-20. PubMed ID: 26700670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis.
    Gong L; Wang C; Gao Y; Wang J
    Biomed Pharmacother; 2016 Oct; 83():58-63. PubMed ID: 27470550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH; Zhang HH; Xu HF; Duan YJ; Li Q; Huang B
    Genet Mol Res; 2015 Dec; 14(4):15948-54. PubMed ID: 26662386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM; Meng FM; Song XL
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):973-977. PubMed ID: 28338199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues.
    Ajdarkosh H; Dadpay M; Yahaghi E; Pirzaman ER; Fayyaz AF; Darian EK; Mokarizadeh A
    Diagn Pathol; 2015 Aug; 10():135. PubMed ID: 26248880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
    Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
    J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The deregulation of miR-133b is associated with poor prognosis in bladder cancer.
    Shi Z; Kadeer A; Wang M; Wen B; Li M; Huang J; Gao Y; Liu E; Liu D; Jia D; Liang C
    Pathol Res Pract; 2019 Feb; 215(2):354-357. PubMed ID: 30591241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
    Luo M; Shen D; Wang W; Xian J
    Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of Increased Expression of MicroRNA-155 in Bladder Cancer and Prognosis.
    Wang H; Men CP
    Lab Med; 2015; 46(2):118-22. PubMed ID: 25918190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-335 represents an independent prognostic marker in cervical cancer.
    Wang C; Jiang T
    Tumour Biol; 2015 Aug; 36(8):5825-30. PubMed ID: 25712373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
    Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
    Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
    Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
    Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram.
    Juracek J; Stanik M; Vesela P; Radova L; Dolezel J; Svoboda M; Slaby O
    Urol Oncol; 2019 Mar; 37(3):184.e1-184.e7. PubMed ID: 30446443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma.
    Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y
    J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.